On February 17, 2026, Resolute Capital Asset Partners disclosed a buy of 240,000 shares of The Andersons (NASDAQ:ANDE), an estimated $11.74 million trade based on quarterly average pricing. What happened According to a SEC filing dated February 17, 2026, Resolute Capital Asset Partners increased its position in The Andersons by 240,000 shares during the fourth quarter. The estimated transaction value was $11.74 million, calculated using the mean unadjusted closing price for the quarter. The overall value ...

Industry Overview - The Zacks Chemicals Specialty industry is experiencing demand weakness primarily due to sluggishness in Europe, a slow economic recovery in China, and disruptions from tariffs [1] - The industry includes manufacturers of specialty chemical products used in various end-use markets such as textiles, automotive, electronics, and agriculture [3] Current Challenges - Companies in the chemical specialty space are facing headwinds from demand softness in building and construction and industrial end markets, particularly in Europe and China, due to economic slowdowns [4] - Elevated borrowing costs and inflation are negatively impacting the residential construction industry, while manufacturing activities have weakened amid softer demand for goods [4] - Specialty chemical makers are dealing with raw material and energy cost inflation, supply-chain disruptions, and elevated logistics and labor costs, which are pressuring margins [5] Strategic Responses - Industry players are implementing strategic measures such as cost-cutting, productivity improvements, and expansion into high-growth markets to navigate the challenging environment [6] - Companies are focusing on operational efficiency and strengthening their balance sheets to boost cash flows amid ongoing headwinds [6] Market Performance - The Zacks Chemicals Specialty industry has underperformed the S&P 500 and the broader Zacks Basic Materials sector over the past year, gaining only 0.4% compared to the S&P 500's 16.7% and the sector's 38% increase [9] - The industry currently trades at a trailing 12-month EV/EBITDA ratio of 12.75X, below the S&P 500's 18.97X and the sector's 16.71X [12] Company Highlights - **Sociedad Quimica y Minera de Chile S.A. (SQM)**: This company is benefiting from being a low-cost producer of potassium chloride and lithium, with strong demand driven by electric vehicle sales. SQM has an expected earnings growth of 180.6% for 2026, with a Zacks Rank of 1 (Strong Buy) [15][16] - **Element Solutions Inc (ESI)**: ESI is positioned for growth in the electronics sector, with strong organic growth offsetting weakness in industrial markets. The company has an expected earnings growth of 15.6% for 2026 and carries a Zacks Rank of 3 (Hold) [20][21] - **Flexible Solutions International Inc (FSI)**: FSI specializes in biodegradable products and has an expected earnings growth rate of 212.5% for 2026, maintaining a Zacks Rank of 3 [23][25]

Core Insights - Compass Minerals International, Inc. is a significant player in the essential minerals market, operating in the U.S., Canada, Brazil, and the U.K., with three main segments: Salt, Plant Nutrition North America, and Plant Nutrition South America [1] Stock Performance - The stock price of Compass Minerals increased by 8.8% in the latest trading session, indicating strong investor interest, although Deutsche Bank's price target of $55 suggests cautious optimism for further near-term price increases [2][6] - The consensus price target for Compass Minerals has risen from $23.25 to $25 over the past month, reflecting a more optimistic outlook from analysts [3] Financial Performance - In the fourth quarter of fiscal year 2025, Compass Minerals reported strong performance, with revenue and adjusted earnings per share exceeding expectations, driven by increased volume in the Salt segment and higher pricing in the Plant Nutrition segment [4] - Analysts from Deutsche Bank have revised their forecasts for the fourth quarter, predicting a narrower loss, which supports a positive outlook for the company's stock performance [5][6]

Core Viewpoint - The reclassification of marijuana by President Trump as a Schedule III drug opens up significant opportunities for the cannabis industry, particularly for companies like Scott's Miracle Grow and its Hawthorne subsidiary, which provides cannabis growing supplies [1][4][6]. Company Developments - Scott's Miracle Grow plans to combine its Hawthorne subsidiary with a dedicated pure-play cannabis company next year, indicating a strategic shift to capitalize on the evolving cannabis market [2][12]. - The CEO of Scott's Miracle Grow, Jim Hagadorn, expressed enthusiasm about the executive order, highlighting the culmination of a decade-long effort to achieve this change [3][4]. Industry Implications - The reclassification allows for increased medical research on cannabis, which was previously restricted under Schedule I classification, thus potentially leading to new medical applications and benefits [4][6]. - Legal cannabis businesses can now benefit from a reduced federal tax rate of 21%, down from an 80% rate, which was previously punitive and hindered profitability [6][7]. - The change is expected to help legitimate markets thrive while reducing the influence of illicit operators and protecting children [7][8]. Market Reactions - Following the announcement, there was initial stock price volatility, with some stocks experiencing a spike before settling down, indicating a "sell on the news" reaction from investors [11].